GO:0004895 cell adhesion receptor activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0004895 (cell adhesion receptor activity) describes the molecular function by which cell-surface receptors bind extracellular matrix components or counter-receptors on other cells to mediate adhesion and initiate intracellular signaling.
• Integrins and cadherins are the canonical cell adhesion receptors, but the urokinase receptor (uPAR) and its co-receptor partners also fulfill this function through vitronectin binding and focused cell-surface proteolysis.
• Adhesion receptor engagement is not merely structural; it actively regulates nuclear receptor activity, gene expression, and survival signaling through Stat3 and Akt pathways.
• Signaling downstream of adhesion receptors is controlled by kinases such as Btk and PLCgamma2, and by cytoskeletal adaptors including moesin and merlin.
• Dysregulated cell adhesion receptor activity is implicated in cancer metastasis, immune cell recruitment, and vascular pathology, making it a high-value target for functional genomics.
• CRISPR knockout, point-mutation, knock-in, and overexpression models enable precise dissection of adhesion receptor function in disease-relevant cell types.
Description
Cell adhesion receptor activity (GO:0004895) is a molecular function that enables a cell-surface protein to bind an extracellular matrix component or a receptor on an adjacent cell, thereby mediating physical adhesion and initiating intracellular signaling. This dual role distinguishes adhesion receptors from purely structural adhesion molecules: they are signal-transducing machines that convert mechanical and chemical cues from the microenvironment into changes in cell behavior. The QuickGO definition explicitly includes integrins and cadherins as examples, but the functional category extends to other receptors such as the urokinase receptor (uPAR), which cooperates with vitronectin to drive adhesion and signaling. For researchers, GO:0004895 matters because adhesion receptor activity sits at the intersection of cell biology, immunology, and cancer biology. Engagement of these receptors can directly modulate nuclear receptor activity and transcriptional programs, and it controls survival versus apoptosis decisions through Stat3 and Akt signaling. In B lymphocytes, antigen receptor signaling controls integrin activity through Btk and PLCgamma2, illustrating how adhesion receptor function is integrated with immune receptor cascades. In endothelial cells, uPAR-dependent adhesion and migration are regulated by moesin and merlin, linking the cytoskeleton to angiogenic behavior. This article synthesizes authoritative QuickGO annotation data with verified PubMed literature to provide a research-grade overview of GO:0004895. We cover the biological process of adhesion receptor engagement, the structural composition of adhesion complexes, the molecular mechanisms of signaling, key genes, disease associations, and the CRISPR-based methods used to study this function in model systems.
cell adhesion receptor activity At A Glance
| GO ID | GO:0004895 |
|---|---|
| GO term | cell adhesion receptor activity |
| Ontology | molecular_function |
| Synonym | none |
| Definition | The binding by a cell-adhesion protein on the cell surface to an extracellular matrix component, to mediate adhesion of the cell to the external substrate or to another cell and to initiate intracellular signaling. Cell adhesion receptors include integrins and cadherins. |
| Major function | Mediates cell-matrix and cell-cell adhesion while initiating intracellular signaling cascades. |
| Representative receptors | Integrins, cadherins, urokinase receptor (uPAR) in complex with vitronectin. |
| Key signaling outputs | Nuclear receptor activity, Stat3 versus Akt survival signaling, Btk/PLCgamma2 pathways. |
| Cytoskeletal regulators | Moesin and merlin modulate uPAR-dependent adhesion and migration. |
What Is GO:0004895?
In our own words, GO:0004895 (cell adhesion receptor activity) is the molecular function performed by a cell-surface protein that binds to an extracellular matrix component or to a molecule on another cell, thereby (1) physically attaching the cell to its external substrate or to a neighboring cell and (2) initiating intracellular signaling. The QuickGO definition names integrins and cadherins as representative examples. This function is distinct from passive adhesion because it explicitly requires signal initiation, meaning the receptor must be capable of transmitting information into the cell after ligand engagement.
Why Is cell adhesion receptor activity Important in Cell Biology?
Cell adhesion receptor activity is fundamentally important because it couples the physical state of a cell to its transcriptional and survival programs. Adhesion signals can regulate nuclear receptor activity, meaning that the extracellular matrix is not a passive scaffold but an active participant in gene regulation. This function also determines whether a cell survives or dies under stress, with Stat3 and Akt acting as opposing or complementary effectors downstream of cell-cell and cell-matrix adhesion. In the immune system, adhesion receptor activity is required for lymphocyte recruitment and activation, and it is controlled by antigen receptor signaling through Btk and PLCgamma2. In vascular biology, uPAR-dependent adhesion and migration are regulated by moesin and merlin, which influence angiogenesis. Because of these roles, cell adhesion receptor activity is a central node in cancer metastasis, inflammation, and tissue remodeling, and it is a prime target for functional genomics and therapeutic intervention.
• Adhesion receptor engagement directly regulates nuclear receptor activity and downstream gene expression.
• It controls cell survival decisions through Stat3 versus Akt signaling pathways.
• Integrin activity in B cells is controlled by the B cell antigen receptor via Btk and PLCgamma2, linking adhesion to immune activation.
• uPAR-vitronectin interactions mediate adhesion and signaling, and are implicated in focused cell-surface proteolysis.
• Moesin and merlin regulate uPAR-dependent endothelial cell migration, adhesion, and angiogenesis.
• Thrombin induces mast cell adhesion to fibronectin through protease-activated receptor-1, showing G-protein-coupled receptor crosstalk with adhesion.
• PAI-1 regulates cell adhesion, connecting the fibrinolytic system to adhesion receptor function.
• Dysregulated adhesion receptor activity contributes to cancer metastasis and poor clinical outcomes.
• Adhesion receptors are attractive drug targets because they are cell-surface accessible and functionally tractable.
• CRISPR-based models allow causal testing of adhesion receptor genes in disease-relevant contexts.
What Happens During cell adhesion receptor activity?
Ligand engagement and receptor activation
In simple terms: The adhesion receptor grabs onto a partner outside the cell, which switches the receptor into an active state.
Cell adhesion receptor activity begins when a cell-surface receptor binds an extracellular matrix component or a counter-receptor on another cell. For integrins and cadherins, this binding induces conformational changes that convert the receptor from a low-affinity to a high-affinity state and cluster the receptors into adhesion complexes. The urokinase receptor (uPAR) provides a non-integrin example: its interaction with vitronectin mediates adhesion and simultaneously initiates signaling, a process coupled to focused cell-surface proteolysis. This step is not passive; ligand engagement is the trigger for all downstream intracellular events.
Initiation of intracellular signaling
In simple terms: Once the receptor is engaged, it sends a signal into the cell that changes gene expression and cell behavior.
After ligand binding, adhesion receptors initiate intracellular signaling. This can include direct regulation of nuclear receptor activity, as demonstrated for cell adhesion signals that control nuclear receptor function. In B lymphocytes, the B cell antigen receptor controls integrin activity through Btk and PLCgamma2, showing that adhesion receptor signaling is integrated with immune receptor cascades. Downstream of adhesion, Stat3 and Akt pathways mediate survival and metastatic behavior, with the balance between these effectors determining cell fate. Thus, the signaling output of GO:0004895 is context-dependent and can reprogram transcription.
Cytoskeletal coupling and migration
In simple terms: The receptor connects to the cell's internal skeleton, allowing the cell to pull itself forward or hold its position.
Adhesion receptors are physically linked to the actin cytoskeleton, and this coupling is required for migration and morphological change. Moesin and merlin regulate uPAR-dependent endothelial cell migration, adhesion, and angiogenesis, demonstrating that cytoskeletal adaptors are essential effectors of adhesion receptor activity. The urokinase receptor system also illustrates how adhesion and proteolysis are coordinated at the cell surface to promote migration. In mast cells, thrombin induces adhesion to fibronectin through protease-activated receptor-1, further highlighting the integration of adhesion with cytoskeletal remodeling.
Regulation by proteolysis and protease inhibitors
In simple terms: Enzymes that cut proteins and their inhibitors can dial adhesion up or down.
Cell adhesion receptor activity is regulated by the plasminogen activation system. PAI-1 regulates cell adhesion, linking fibrinolytic balance to adhesion receptor function. The urokinase receptor provides focused cell-surface proteolysis that modulates adhesion and signaling, and its interaction with vitronectin is a key regulatory node. This means that proteases and their inhibitors are not merely degradative enzymes but active regulators of GO:0004895.
Integration with survival and transcriptional programs
In simple terms: Adhesion signals tell the cell whether to live, grow, or move, by changing which genes are turned on.
The ultimate output of cell adhesion receptor activity is a change in cell behavior, often through transcriptional reprogramming. Adhesion signals regulate nuclear receptor activity, directly connecting the cell surface to the nucleus. Stat3 and Akt act as downstream effectors that determine survival versus metastasis in response to cell-cell and cell-matrix adhesion. This integration ensures that adhesion is not an isolated mechanical event but a core component of cellular decision-making.
Key Genes Involved in GO:0004895 cell adhesion receptor activity
The following genes and proteins are central to cell adhesion receptor activity (GO:0004895), based on the verified literature and the QuickGO definition.
| Gene | Major Role | Research Relevance |
|---|---|---|
| ITGB1 (Integrin beta-1) | Forms integrin heterodimers that bind extracellular matrix ligands and initiate adhesion signaling. | Core adhesion receptor subunit; knockout and point-mutation models reveal ligand specificity and signaling outputs. |
| ITGA5 (Integrin alpha-5) | Pairs with beta-1 to form fibronectin receptor; mediates cell-matrix adhesion. | Target for studying fibronectin-dependent adhesion in cancer and immune cells. |
| CDH1 (E-cadherin) | Mediates calcium-dependent cell-cell adhesion and signaling. | Loss-of-function is a hallmark of epithelial-mesenchymal transition; knock-in reporters track junction dynamics. |
| CDH2 (N-cadherin) | Mediates cell-cell adhesion in neural and mesenchymal cells. | Important for neural development and cancer invasion models. |
| PLAUR (uPAR) | Binds vitronectin and urokinase; mediates adhesion, proteolysis, and signaling. | Key node linking proteolysis to adhesion; knockout and overexpression models study migration and angiogenesis. |
| VTN (Vitronectin) | Extracellular matrix ligand for uPAR and integrins; supports adhesion and signaling. | Ligand-side manipulation in adhesion assays and matrix remodeling studies. |
| STAT3 | Transcription factor downstream of adhesion that promotes survival and metastasis. | Reporter and knockout models dissect Stat3-dependent adhesion signaling. |
| AKT1 | Serine/threonine kinase downstream of adhesion that promotes survival. | Phospho-Akt readouts quantify adhesion-dependent survival signaling. |
| BTK | Kinase required for antigen receptor control of integrin activity in B cells. | Loss-of-function models reveal immune adhesion defects. |
| PLCG2 | Phospholipase C gamma 2; mediates B cell antigen receptor control of integrin activity. | Point mutations in PLCG2 are linked to immune dysregulation; useful for signaling dissection. |
| MSN (Moesin) | Cytoskeletal adaptor regulating uPAR-dependent endothelial migration and adhesion. | Knockout and phospho-mutant models study cytoskeletal coupling. |
| NF2 (Merlin) | Cytoskeletal adaptor regulating uPAR-dependent adhesion and angiogenesis. | Tumor suppressor; loss-of-function models link adhesion to vascular pathology. |
| F2R (PAR-1) | Protease-activated receptor-1 mediates thrombin-induced mast cell adhesion to fibronectin. | GPCR-adhesion crosstalk models in inflammation. |
| SERPINE1 (PAI-1) | Regulates cell adhesion through the fibrinolytic system. | Modulates adhesion in matrix remodeling and cancer models. |
| PLAU (uPA) | Binds uPAR and activates focused proteolysis that modulates adhesion. | Overexpression and knockout models study invasion and migration. |
| ITGAV (Integrin alpha-V) | Forms vitronectin-binding integrins with beta subunits. | Target for angiogenesis and metastasis studies. |
| ITGB3 (Integrin beta-3) | Pairs with alpha-V to bind vitronectin and other ligands. | Platelet and cancer adhesion models. |
| CDH5 (VE-cadherin) | Endothelial cell-cell adhesion receptor. | Vascular permeability and angiogenesis models. |
How Is cell adhesion receptor activity Regulated?
Cell adhesion receptor activity is regulated at multiple levels. Extracellularly, ligand availability and proteolytic processing control receptor engagement; the urokinase receptor system exemplifies this through focused cell-surface proteolysis and interaction with vitronectin. PAI-1 regulates cell adhesion, linking the fibrinolytic system to adhesion receptor function. Intracellularly, kinases such as Btk and PLCgamma2 control integrin activity downstream of the B cell antigen receptor. Cytoskeletal adaptors including moesin and merlin regulate uPAR-dependent adhesion and migration. Downstream signaling through Stat3 and Akt determines whether adhesion promotes survival or metastasis. Finally, adhesion signals can directly regulate nuclear receptor activity, providing a feedback loop between the cell surface and transcription.
cell adhesion receptor activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| PLAUR (uPAR) | Cancer invasion, angiogenesis, inflammation | Knockout and overexpression in endothelial and cancer cell lines; migration and adhesion assays. |
| STAT3 | Metastasis and survival signaling | Knockout and phospho-mutant knock-in in cancer cell lines; adhesion-dependent survival assays. |
| BTK | Immune dysregulation and B cell adhesion defects | Knockout and point-mutation models in B cell lines; integrin activation assays. |
| NF2 (Merlin) | Vascular pathology and tumor suppression | Knockout in endothelial cells; angiogenesis and adhesion assays. |
| SERPINE1 (PAI-1) | Fibrosis and matrix remodeling | Overexpression and knockout in fibroblast models; adhesion and matrix assays. |
Cancer metastasis and invasion
Dysregulated cell adhesion receptor activity is a hallmark of cancer progression. Stat3 and Akt signaling downstream of cell-cell and cell-matrix adhesion controls survival and metastatic behavior, and the balance between these pathways influences whether tumor cells survive in foreign microenvironments. The urokinase receptor and its interaction with vitronectin promote adhesion, proteolysis, and migration, all of which are required for invasion. PAI-1 regulation of cell adhesion further links the fibrinolytic system to tumor cell dissemination. Targeting adhesion receptor signaling is therefore a rational strategy in metastasis research.
Immune and inflammatory disorders
Adhesion receptor activity is essential for immune cell recruitment and activation. In B lymphocytes, the B cell antigen receptor controls integrin activity through Btk and PLCgamma2, and defects in this axis can impair immune responses. Thrombin induces mast cell adhesion to fibronectin via protease-activated receptor-1, connecting coagulation to mast cell-driven inflammation. These findings position GO:0004895 as a therapeutic node in autoimmune and inflammatory diseases.
Vascular and angiogenic pathology
Endothelial cell adhesion and migration are regulated by uPAR, moesin, and merlin, and these processes are required for angiogenesis. Disruption of these regulators can lead to abnormal vessel formation and vascular permeability. The urokinase receptor system also contributes to endothelial cell migration and adhesion, making it relevant to ischemic and tumor angiogenesis.
Fibrotic and matrix remodeling diseases
PAI-1 regulation of cell adhesion connects the fibrinolytic system to matrix remodeling, which is central to fibrosis. Adhesion receptor activity influences how cells interact with a remodeling extracellular matrix, and dysregulation can promote excessive deposition of matrix components. This makes adhesion receptors potential targets in fibrotic disease research.
From cell adhesion receptor activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is the adhesion receptor gene required for cell-matrix adhesion? | CRISPR knockout in a relevant cell line followed by adhesion assays. |
| Does a specific phosphorylation site control adhesion signaling? | Point-mutation knock-in of the phospho-site. |
| How does a disease-associated variant affect adhesion receptor function? | Knock-in of the variant allele and comparison to wild-type. |
| Where and when is the receptor expressed during migration? | Tagged knock-in with fluorescent or epitope tag. |
| Does overexpression of the receptor drive invasion? | Overexpression model in a low-expressing cell line. |
| Which downstream effectors mediate adhesion-dependent survival? | Knockout of candidate effectors (e.g., STAT3, AKT1) in adhesion assays. |
How to Study the cell adhesion receptor activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Adhesion assay | Attachment of cells to matrix ligands | Testing whether a gene is required for cell-matrix adhesion. |
| Phospho-Western blot | Activation of Akt, Stat3, or other effectors | Quantifying signaling downstream of adhesion receptors. |
| Transwell migration | Directed cell movement | Assessing uPAR- and integrin-dependent migration. |
| Invasion assay | Degradation and penetration of matrix | Studying metastatic potential. |
| Reporter assay | Nuclear receptor or transcription factor activity | Linking adhesion to transcriptional regulation. |
| RNA-seq | Global gene expression changes | Identifying transcriptional programs downstream of adhesion. |
| Live-cell imaging | Dynamic adhesion and cytoskeletal changes | Visualizing adhesion complex turnover and migration. |
| Co-immunoprecipitation | Protein-protein interactions in adhesion complexes | Mapping receptor-ligand and receptor-adaptor interactions. |
Adhesion assays
Adhesion assays measure the ability of cells to attach to extracellular matrix proteins such as fibronectin or vitronectin. These assays are used to quantify the functional output of cell adhesion receptor activity after genetic perturbation. They can be combined with blocking antibodies or ligand-coated plates to dissect receptor-ligand specificity.
Signaling readouts (phospho-protein analysis)
Western blotting and phospho-specific antibodies quantify activation of downstream kinases such as Akt and Stat3 following adhesion. This approach is essential for determining whether a genetic perturbation alters the signaling arm of GO:0004895. Kinase inhibitors and point mutations can be used to establish causality.
Migration and invasion assays
Transwell migration and Matrigel invasion assays measure the functional consequence of adhesion receptor activity in motile cells. These assays are particularly useful for studying uPAR-dependent migration and the roles of moesin and merlin. They can be combined with time-lapse imaging to assess dynamics.
Transcriptional and nuclear receptor reporter assays
Because adhesion signals can regulate nuclear receptor activity, reporter assays and RNA-seq are used to measure transcriptional outputs. These methods connect cell-surface adhesion events to changes in gene expression, providing a mechanistic link between GO:0004895 and downstream cellular programs.
How CRISPR Can Be Used to Study GO:0004895 cell adhesion receptor activity
Knockout
CRISPR knockout is used to eliminate a candidate adhesion receptor gene and test whether it is required for adhesion, signaling, and downstream phenotypes. For example, knocking out PLAUR or ITGB1 allows researchers to measure loss of adhesion to vitronectin or fibronectin and to assess changes in Akt or Stat3 signaling. Knockout models are also valuable for validating whether a gene is causally involved in migration or invasion.
Point Mutation
Point-mutation knock-in via CRISPR is used to dissect specific residues required for adhesion receptor function. For instance, mutating phosphorylation sites in signaling effectors such as Stat3 or in cytoskeletal adaptors can reveal which residues are required for adhesion-dependent survival or migration. Point mutations in BTK or PLCG2 can be introduced to model immune dysregulation and to test integrin activation defects.
Knock-in
Knock-in models include tagged receptors (e.g., fluorescent or epitope tags) to track localization and dynamics, as well as disease-associated variant knock-ins to test functional consequences. Tagged knock-in of adhesion receptors enables live-cell imaging of adhesion complexes. Variant knock-in can be used to determine whether a specific allele alters adhesion or signaling.
Overexpression
Overexpression models are used to test whether increased levels of an adhesion receptor or its regulators drive phenotypic changes such as enhanced migration or invasion. Overexpressing PLAUR or SERPINE1 can promote adhesion-dependent behaviors and matrix remodeling. These models complement knockout studies by providing gain-of-function evidence for causality.
How EDITGENE Supports cell adhesion receptor activity Research
Researchers studying cell adhesion receptor activity-related genes often need to determine whether a candidate gene is causally involved in adhesion, signaling, or disease phenotypes. This requires precise genetic models that can isolate the function of a single gene or residue in a relevant cellular context. EDITGENE provides end-to-end CRISPR services to generate such models, from knockout and point-mutation cell lines to knock-in reporters and overexpression systems, supported by library screening and bioinformatics.
Contact EDITGENE today to design your custom CRISPR model for cell adhesion receptor activity research.
Frequently Asked Questions About cell adhesion receptor activity
What is cell adhesion receptor activity (GO:0004895)?
It is the molecular function by which a cell-surface protein binds an extracellular matrix component or a counter-receptor on another cell, mediating adhesion and initiating intracellular signaling. Integrins and cadherins are examples.
What genes are involved in cell adhesion receptor activity?
Key genes include ITGB1, ITGA5, CDH1, CDH2, PLAUR, VTN, STAT3, AKT1, BTK, PLCG2, MSN, NF2, F2R, SERPINE1, PLAU, ITGAV, ITGB3, and CDH5.
How does cell adhesion receptor activity initiate signaling?
Ligand engagement induces receptor clustering and conformational changes that activate intracellular kinases and adaptors, leading to changes in nuclear receptor activity and gene expression.
What is the role of uPAR in cell adhesion receptor activity?
uPAR binds vitronectin and urokinase, mediating adhesion and focused cell-surface proteolysis, and it signals through pathways regulated by moesin and merlin.
How is cell adhesion receptor activity regulated?
It is regulated by ligand availability, proteolysis, protease inhibitors such as PAI-1, kinases like Btk and PLCgamma2, and cytoskeletal adaptors including moesin and merlin.
What diseases are linked to cell adhesion receptor activity?
Cancer metastasis, immune and inflammatory disorders, vascular and angiogenic pathology, and fibrotic diseases are linked to dysregulated adhesion receptor function.
How do CRISPR knockouts help study cell adhesion receptor activity?
Knockouts eliminate a candidate gene to test whether it is required for adhesion, signaling, and phenotypes such as migration or survival.
What methods measure cell adhesion receptor activity?
Adhesion assays, phospho-Western blots, migration and invasion assays, reporter assays, RNA-seq, live-cell imaging, and co-immunoprecipitation are commonly used.
Can point mutations be used to study adhesion receptor signaling?
Yes, point-mutation knock-in can dissect phosphorylation sites and disease variants in genes such as STAT3, BTK, and PLCG2.
Why is cell adhesion receptor activity important for cancer research?
It controls survival and metastatic behavior through Stat3 and Akt signaling, and it promotes invasion via uPAR-vitronectin interactions.
Conclusion
Cell adhesion receptor activity (GO:0004895) is a molecular function that couples extracellular adhesion to intracellular signaling, with integrins, cadherins, and the urokinase receptor system as key players. Its downstream effects on nuclear receptor activity, Stat3/Akt signaling, and cytoskeletal regulation make it central to cancer, immunity, and vascular biology. Understanding this function requires precise genetic models, and CRISPR-based knockout, point-mutation, knock-in, and overexpression approaches provide the causal evidence needed to link genes to phenotypes. As the literature continues to expand, functional genomics screens and bioinformatics will be essential for mapping the full regulatory network of cell adhesion receptor activity. Researchers can accelerate this work by leveraging validated CRISPR cell models and screening services tailored to adhesion biology.
References
- 1. Sugimoto K et al.. 2019. Cell adhesion signals regulate the nuclear receptor activity.. Proc Natl Acad Sci U S A 116(49):24600-24609 PMID: 31740618
- 2. Madsen CD et al.. 2008. The interaction between urokinase receptor and vitronectin in cell adhesion and signalling.. Eur J Cell Biol 87(8-9):617-29 PMID: 18353489
- 3. Spaargaren M et al.. 2003. The B cell antigen receptor controls integrin activity through Btk and PLCgamma2.. J Exp Med 198(10):1539-50 PMID: 14610042
- 4. Blasi F et al.. 2010. The urokinase receptor: focused cell surface proteolysis, cell adhesion and signaling.. FEBS Lett 584(9):1923-30 PMID: 20036661
- 5. Niit M et al.. 2015. Cell-cell and cell-matrix adhesion in survival and metastasis: Stat3 versus Akt.. Biomol Concepts 6(5-6):383-99 PMID: 26565555
- 6. Degryse B et al.. 2017. Moesin and merlin regulate urokinase receptor-dependent endothelial cell migration, adhesion and angiogenesis.. Int J Biochem Cell Biol 88:14-22 PMID: 28473293
- 7. Vliagoftis H. 2002. Thrombin induces mast cell adhesion to fibronectin: evidence for involvement of protease-activated receptor-1.. J Immunol 169(8):4551-8 PMID: 12370392
- 8. Loskutoff DJ et al.. 1999. Regulation of cell adhesion by PAI-1.. APMIS 107(1):54-61 PMID: 10190280
